References
- United States Centers for Disease Control and Prevention. FastStats: Sleep in adults. https://www.cdc.gov/sleep/data-research/facts-stats/adults-sleep-facts-and-stats.html
- Ramar K, Malhotra RK, Carden KA, et al. Sleep is essential to health: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. Oct 1 2021;17(10):2115-2119. doi:10.5664/jcsm.9476
- Healthy People 2030. Sleep. Web page. U. S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Accessed July 18, 2024. https://health.gov/healthypeople/objectives-and-data/browse-objectives/sleep
- Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. Feb 15 2017;13(02):307-349. doi:10.5664/jcsm.6470
- Vaillancourt R, Gallagher S, Cameron JD, Dhalla R. Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. May-Jun 2022;155(3):175-180. doi:10.1177/17151635221089617
- Hafner M, Stepanek M, Taylor J, Troxel WM, van Stolk C. Why sleep matters-the economic costs of insufficient sleep: A cross-country comparative analysis. RAND EUROPE; 2017.
- Bugatti M, Owen J, Reese RJ, et al. Access to care and cost as predictors of early psychotherapy dropout: Findings from a technology-enabled practice research group. Practice Innovations. 2023;8(1):62-74. doi:10.1037/pri0000200
- Manber R, Simpson N, Gumport NB. Perspectives on increasing the impact and reach of CBT-I. Sleep. Dec 11 2023;46(12)doi:10.1093/sleep/zsad168
- Dokkedal-Silva V, Oliveira MGM, Galduróz JCF, Tufik S, Andersen ML. The effect of sleep medications on prospective and retrospective memory: a population-based study. Prog Neuropsychopharmacol Biol Psychiatry. Jan 10 2021;104:110043. doi:10.1016/j.pnpbp.2020.110043
- Edinoff AN, Nix CA, Hollier J, et al. Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurol Int. Nov 10 2021;13(4):594-607. doi:10.3390/neurolint13040059
- Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. Mar 1 2022;5(3):e222106. doi:10.1001/jamanetworkopen.2022.2106
- Tervo-Clemmens B, Schmitt W, Wheeler G, et al. Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns. Drug Alcohol Depend. Feb 1 2023;243:109760. doi:10.1016/j.drugalcdep.2022.109760
- Kisiolek JN, Flores VA, Ramani A, Butler B, Haughian JM, Stewart LK. Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity. Nutrients. Sep 27 2023;15(19)doi:10.3390/nu15194173
- Ried K, Tamanna T, Matthews S, Sali A. Medicinal cannabis improves sleep in adults with insomnia: a randomised double‐blind placebo‐controlled crossover study. J Sleep Res. Jun 2022;32(3):e13793. doi:10.1111/jsr.13793
- de Almeida CMO, Brito MMC, Bosaipo NB, et al. Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder. Mov Disord. Jul 2021;36(7):1711-1715. doi:10.1002/mds.28577
- Ajzen I. The theory of planned behavior. Article. Organ Behav Hum Decis Process. Dec 1991;50(2):179-211. doi:10.1016/0749-5978(91)90020-t
- Flemyng E, Dwan K, Moore THM, Page MJ, Higgins JPT. Risk of Bias 2 in Cochrane Reviews: a phased approach for the introduction of new methodology. Cochrane Database Syst Rev. 2020;doi:10.1002/14651858.Ed000148
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. doi: 10.1016/0197-2456(86)90046-2
- American Association of Colleges of Nursing. The Essentials: Core competencies for professional nursing education. 2021;